Schnieders Capital Management LLC Has $563,000 Position in Clorox Company (The) (CLX)

Schnieders Capital Management LLC decreased its stake in shares of Clorox Company (The) (NYSE:CLX) by 2.6% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 4,225 shares of the company’s stock after selling 115 shares during the period. Schnieders Capital Management LLC’s holdings in Clorox Company (The) were worth $563,000 as of its most recent filing with the SEC.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after buying an additional 649,766 shares during the last quarter. BlackRock Inc. boosted its position in shares of Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after buying an additional 9,698,542 shares during the last quarter. State Street Corp boosted its position in shares of Clorox Company (The) by 2.2% in the first quarter. State Street Corp now owns 7,648,999 shares of the company’s stock valued at $1,031,304,000 after buying an additional 167,689 shares during the last quarter. Parnassus Investments CA purchased a new position in shares of Clorox Company (The) during the first quarter valued at approximately $434,255,000. Finally, Valueinvest Asset Management S.A. boosted its position in shares of Clorox Company (The) by 6.9% in the first quarter. Valueinvest Asset Management S.A. now owns 1,580,400 shares of the company’s stock valued at $213,085,000 after buying an additional 102,300 shares during the last quarter. 69.83% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Company (NYSE:CLX) traded up 0.41% during midday trading on Friday, reaching $137.73. 734,445 shares of the company’s stock were exchanged. The company has a market cap of $17.78 billion, a P/E ratio of 25.82 and a beta of 0.40. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The company has a 50 day moving average price of $133.55 and a 200 day moving average price of $134.12.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business’s revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.30 earnings per share. On average, equities analysts anticipate that Clorox Company will post $5.67 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Schnieders Capital Management LLC Has $563,000 Position in Clorox Company (The) (CLX)” was posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.com-unik.info/2017/08/19/schnieders-capital-management-llc-sells-115-shares-of-clorox-company-the-clx-updated.html.

A number of analysts have recently issued reports on CLX shares. BidaskClub lowered shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Zacks Investment Research raised shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target for the company in a research report on Tuesday, July 4th. Deutsche Bank AG reaffirmed a “hold” rating and set a $137.00 price objective (up previously from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Vetr raised shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price objective on the stock in a research report on Monday, April 24th. Finally, Jefferies Group LLC set a $138.00 price objective on shares of Clorox Company (The) and gave the company a “hold” rating in a research report on Wednesday, May 3rd. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company’s stock. Clorox Company (The) presently has an average rating of “Hold” and a consensus price target of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

What are top analysts saying about Clorox Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Clorox Company (The) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit